Azadeh Vahdat, Foreign Qualified Lawyer in London

Azadeh is an Australian qualified solicitor and joined EIP from one of the largest specialist IP firms in Australia. She has advised both innovator and generic multi-national pharmaceutical companies throughout all stages of contentious patent proceedings, with experience in small-molecules, biologics and biosimilars. She notably represented ICOS (Eli Lilly) in a high profile case in the Federal Court of Australia.

Azadeh has a BSc in Biomedical Science and a Juris Doctor from Murdoch University, and a Graduate Diploma of Legal Practice from the Australian College of Law.

Experience

Apotex Pty Ltd v ICOS Corporation (No 3) [2018] FCA 1204
Apotex Pty Ltd v ICOS Corporation [2017] FCA 466

Published articles

January 2023
LSIPR, Why Novartis lost its treatment dispute with Teva (link)
January 2023
EIP Updates, Court of Appeal refuses Arrow declaratory relief for Teva in a stand against forum shopping and jurisdictional imperialism (link)
December 2022
EIP Updates, Novartis overloaded with reasons its iron overload treatment Exjade is obvious and not infringed by Teva (link)
August 2022
Company, Women in Law: A Legal Timeline, in celebration of Women’s Equality Day (link)
June 2022
Update, Patents Court affirms power to grant injunctions for pre-grant patents, but Novartis loses on interim relief and refused permission to appeal by Birss LJ for Gilenya® (link)

Education and qualifications

2015 — 2016
Graduate Diploma of Legal Practice , College of Law (Australia)
2011 — 2014
Juris Doctor, Murdoch University
2007 — 2010
BSc Biomedical Science, Murdoch University

Career history

2020 — present
Associate, EIP
2016 — 2019
Lawyer, Wrays
2014 — 2016
Analyst, Deloitte

Languages spoken

Farsi (fluent)